What is the relationship between a rash and Vyvanse (lisdexamfetamine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

If you're experiencing a rash while taking Vyvanse, you should stop taking the medication and contact your healthcare provider immediately, as this could be a sign of an allergic reaction 1.

Potential Causes and Symptoms

Rashes are uncommon but serious side effects of Vyvanse (lisdexamfetamine), which is a stimulant medication used to treat ADHD and binge eating disorder. The rash may appear as red, itchy patches on the skin and could indicate that your body is having an adverse reaction to the medication.

Recommended Course of Action

Your doctor might recommend switching to a different ADHD medication such as methylphenidate (Ritalin, Concerta) or another amphetamine formulation that may not cause the same reaction 1. They might also prescribe antihistamines or topical steroids to help manage the rash symptoms.

Importance of Medical Attention

Allergic reactions occur because your immune system identifies the medication as harmful and releases chemicals that cause inflammation and other symptoms. It is crucial to seek medical attention, especially if the rash is accompanied by other symptoms like difficulty breathing, swelling, or fever.

Key Considerations

When deciding on a new medication, factors such as severity of symptoms, presence of comorbidities, and patients' preferences should be considered 1. Additionally, medication adherence should be regularly assessed, and potential issues in adherence openly discussed to increase medication adherence as early as possible.

Alternative Treatment Options

In general, it is recommended to use stimulants as first-line therapy and non-stimulants as second-line therapy 1. However, the approval statuses of individual medications do vary slightly between different countries and need to be considered. For example, lisdexamfetamine and atomoxetine are approved as first-line therapies in the United States, but as second-line therapies in many European countries.

From the FDA Drug Label

Less commonly reported adverse reactions (less than 1% or less than twice rate of placebo) included ... rash The rash is reported as a less common adverse reaction in patients taking lisdexamfetamine dimesylate capsules, occurring in less than 1% of patients or at a rate less than twice that of the placebo group 2.

From the Research

Rash Associated with Vyvanse

  • There is no direct evidence in the provided studies that specifically addresses the topic of a rash associated with Vyvanse (lisdexamfetamine dimesylate) 3, 4, 5, 6, 7.
  • However, the studies do mention common adverse events associated with Vyvanse, such as decreased appetite, insomnia, upper abdominal pain, headache, irritability, weight loss, and nausea 4, 5, 6, 7.
  • It is possible that a rash could be a rare or uncommon side effect of Vyvanse, but this is not explicitly stated in the provided studies.
  • Further research would be needed to determine the likelihood and characteristics of a rash associated with Vyvanse use.

Common Adverse Events

  • The most common adverse events reported with Vyvanse include:
    • Decreased appetite 5, 6
    • Insomnia 5, 6
    • Upper abdominal pain 6
    • Headache 5, 6, 7
    • Irritability 6
    • Weight loss 5, 6
    • Nausea 6
    • Dry mouth 7

Study Limitations

  • The provided studies primarily focus on the efficacy and safety of Vyvanse for the treatment of attention-deficit/hyperactivity disorder (ADHD) and binge eating disorder, rather than specifically investigating the occurrence of a rash as a side effect 3, 4, 5, 6, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.